Food Effect Study of CTP-656 in Healthy Male Volunteers
NCT02680249 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2016-05-02
Summary
Three way crossover study to assess the bioavailability of 656 under fed and fasted conditions.
Conditions
- Healthy
Interventions
- DRUG
-
CTP-656
Sponsors & Collaborators
-
Concert Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Lana Pilja · Concert Pharmaceuticals, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-02-29
- Primary Completion
- 2016-04-30
- Completion
- 2016-04-30
Countries
- Australia
Study Locations
More Related Trials
-
A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
NCT02480439 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects
NCT03135509 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Participants
NCT02396147 ·Status: COMPLETED ·Phase: PHASE1
-
Food Effects of Single Oral Dose of 600mg TR-701
NCT00671359 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Relative Bioavailability (BA) and Effect of Food on TAK-831 Tablet Formulations in Healthy Participants
NCT03706469 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects
NCT05526742 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects
NCT02183493 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male Volunteers
NCT02183363 ·Status: COMPLETED ·Phase: PHASE1
-
Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets
NCT02266940 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Food Effect on Relative Bioavailability of RP6530 in Healthy Volunteers
NCT02690727 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety and PK Characteristics in Healthy Volunteers
NCT06355349 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Food Effect Study of Two Formulations of TAK-906
NCT04831502 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability of 7 Test Tablet Formulations of JNJ-56021927 With Respect to the Capsule Formulation of JNJ-56021927 in Healthy Male Participants
NCT02031666 ·Status: COMPLETED ·Phase: PHASE1
-
Lesinurad Tablet Relative Bioavailability
NCT01986556 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of PF-06651600 Formulations in Healthy Participants
NCT04004663 ·Status: COMPLETED ·Phase: PHASE1
-
A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants
NCT06006702 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers
NCT05358756 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability Study of 3 Tablet Formulations vs. Capsule Formulation of JNJ-56021927 in Fasting Healthy Male Participants
NCT02160756 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the Blood
NCT03892616 ·Status: COMPLETED ·Phase: PHASE1
-
LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects
NCT01211964 ·Status: COMPLETED ·Phase: PHASE1
-
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
NCT05029518 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult Participants
NCT06577259 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543
NCT05467722 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Comparative Bioavailability Study Of MGCD265 In Healthy Male And Female Volunteers
NCT02117245 ·Status: COMPLETED